NPI: 1194791376 · WASHINGTON, DC 20037 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,750 | $584K |
| 2019 | 43,349 | $596K |
| 2020 | 35,899 | $544K |
| 2021 | 35,678 | $511K |
| 2022 | 30,796 | $806K |
| 2023 | 14,697 | $538K |
| 2024 | 8,099 | $311K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 70,051 | 5,049 | $3.11M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 52,528 | 3,245 | $400K |
| 90945 | 5,010 | 163 | $250K | |
| J1756 | Injection, iron sucrose, 1 mg | 10,890 | 2,629 | $44K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,411 | 738 | $42K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 3,121 | 746 | $30K |
| J1270 | Injection, doxercalciferol, 1 mcg | 36,291 | 2,824 | $8K |
| 83970 | 3,098 | 2,390 | $3K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,104 | 1,451 | $2K |
| 82728 | 3,377 | 2,842 | $985.35 | |
| 83550 | 3,275 | 2,813 | $588.67 | |
| 83540 | 3,682 | 3,090 | $503.26 | |
| 82108 | 899 | 787 | $408.51 | |
| 90674 | 81 | 73 | $394.03 | |
| 85045 | 2,830 | 2,378 | $271.32 | |
| 90732 | 19 | 12 | $215.88 | |
| 85041 | 3,106 | 2,641 | $181.80 | |
| G0008 | Administration of influenza virus vaccine | 109 | 100 | $180.69 |
| 85048 | 3,093 | 2,627 | $151.33 | |
| 82607 | 400 | 342 | $73.65 | |
| 82746 | 466 | 394 | $71.84 | |
| A4657 | Syringe, with or without needle, each | 9,427 | 3,977 | $42.73 |